Literature DB >> 31319987

Characterization of lung adenocarcinoma with a cribriform component reveals its association with spread through air spaces and poor outcomes.

Qifeng Ding1, Donglai Chen2, Xiaofan Wang1, Junmiao Wen3, Chang Chen2, Yongsheng Zhang4, Zhonghua Xu1, Yongbing Chen5.   

Abstract

OBJECTIVE: To further investigate the relationship between the cribriform component and spread through air spaces (STAS), and to unravel the potential pathological mechanism of poor prognoses in lung adenocarcinoma (LUAD) patients with a cribriform component.
METHODS: We retrospectively reviewed the clinicopathological characteristics of 208 LUADs. The cribriform component was identified by hematoxylin and eosin staining. The identification of STAS referred to our previous study. The relationship between the cribriform component and STAS was determined by using a logistic regression model. The effects of the cribriform component and STAS on prognosis were analyzed using a Cox proportional hazards regression model.
RESULTS: LUAD patients with a cribriform component had significantly inferior outcomes and increased risk of both locoregional and distant recurrences when compared with those with no cribriform component (p < 0.001). Among 67 patients with a cribriform component presented, 48 (71.6%) cases had STAS. The logistic regression model identified that the cribriform component was an independent risk factor for the presence of STAS (p = 0.044). Subgroup analysis showed that Crib+ (cribriform component present)/STAS+ (spread through air spaces positive) patients had significantly inferior outcomes when compared with Crib+/STAS- (spread through air spaces negative) patients (p < 0.001). Moreover, the multivariate Cox regression analysis further confirmed that STAS was an independent risk factor for a worsening recurrence-free survival (RFS) (p = 0.001) and overall survival (OS) (p < 0.001) in LUAD patients with a cribriform component.
CONCLUSIONS: Our results indicated that STAS was more frequently observed in LUAD patients with a cribriform component. Moreover, STAS could provide helpful prognostic information in patients with stage I-III LUAD with a cribriform component.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Cribriform component; Lung adenocarcinoma; Prognosis; Spread through air spaces

Mesh:

Year:  2019        PMID: 31319987     DOI: 10.1016/j.lungcan.2019.06.027

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis.

Authors:  Jung-Soo Pyo; Nae Yu Kim
Journal:  Diagnostics (Basel)       Date:  2022-04-28

Review 2.  Current status and perspectives of spread through air spaces in lung cancer.

Authors:  Toshihiro Ikeda; Kyuichi Kadota; Tetsuhiko Go; Reiji Haba; Hiroyasu Yokomise
Journal:  Thorac Cancer       Date:  2021-05-05       Impact factor: 3.500

Review 3.  Spread Through Air Spaces (STAS) in Lung Cancer: A Multiple-Perspective and Update Review.

Authors:  Meng Jia; Shili Yu; Hongwen Gao; Ping-Li Sun
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

Review 4.  [Progress in Research on the Cribriform Component in Lung Adenocarcinoma].

Authors:  Qifeng Ding; Donglai Chen; Wei Wang; Yongbing Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-05-26

5.  Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study.

Authors:  Donglai Chen; Xiaofan Wang; Fuquan Zhang; Ruoshuang Han; Qifeng Ding; Xuejun Xu; Jian Shu; Fei Ye; Li Shi; Yiming Mao; Yongbing Chen; Chang Chen
Journal:  Ther Adv Med Oncol       Date:  2020-12-14       Impact factor: 8.168

6.  Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma.

Authors:  Jinsong Bai; Chaoqiang Deng; Qiang Zheng; Di Li; Fangqiu Fu; Yuan Li; Yang Zhang; Haiquan Chen
Journal:  Transl Lung Cancer Res       Date:  2022-07

Review 7.  [A Review on Pathological High-risk Factors and Postoperative Adjuvant Chemotherapy in Stage IA Lung Adenocarcinoma].

Authors:  Chen Shen; Wentao Fang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-08-20

8.  Clinicopathological, Radiological, and Molecular Features of Primary Lung Adenocarcinoma with Morule-Like Components.

Authors:  Li-Li Wang; Li Ding; Peng Zhao; Jing-Jing Guan; Xiao-Bin Ji; Xiao-Li Zhou; Shi-Hong Shao; Yu-Wei Zou; Wei-Wei Fu; Dong-Liang Lin
Journal:  Dis Markers       Date:  2021-06-12       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.